Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad ...

ITAT Chennai ruled that a delay in property registration due to the builder cannot deny a Section 54 deduction if the capital gains were reinvested on time. Timely payments, not registration, are the ...

The All India Institute of Medical Sciences (AIIMS) Delhi has released the mock allotment results for INI CET January 2026 counselling round 1. Candidates can now access the AIIMS INI CET mock ...

On Tuesday, French AI startup Mistral AI released Devstral 2, a 123 billion parameter open-weights coding model designed to ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

A stealthy campaign with 19 extensions on the VSCode Marketplace has been active since February, targeting developers with ...

The Windows 11 25H2 preview build 26220.7344 enables the Model Context Protocol (MCP), an open standard that will allow AI ...

On December 19, at long last, the files will be made public — at least the ones Pam Bondi decides not to hold back.

CLN-049 monotherapy demonstrates promising efficacy, including multiple complete responses and encouraging response durability, in a heavily pretreated all-comer population of patients with R/R AML 31 ...

Issued on behalf of GT Biopharma, Inc.USA News Group News CommentaryVANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination ...

Myelodysplastic syndromes (MDS) are a group of related conditions that interfere with the body’s ability to make healthy blood cells. They are a type of blood cancer. In the early stages of ...

Myelodysplastic Syndrome (MDS) refers to a group of blood cancers. Myelodysplastic syndrome (MDS) used to be referred to as “pre-leukemia” or sometimes “smoldering leukemia.” MDS is a group of cancers ...